Treatment of Cognitive Deficits in Schizophrenia With Atomoxetine: A Case Report

View This PDF

NB: This article is only available as a PDF.

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Schizophrenia patients have deficits in attention, concentration, and information processing that result in significant functional impairment.1 Atomoxetine, a novel cognitive enhancer that can reduce executive function deficits,2 has been postulated to potentially treat these deficits in schizophrenia.3 We report a patient with schizophrenia whose cognitive functioning improved after adjunctive treatment with atomoxetine.​​

J Clin Psychiatry 2007;68(12):1988-1989